Concepts (122)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| RNA, Long Noncoding | 1 | 2019 | 408 | 0.54 | Why? |
| Celiac Disease | 4 | 2019 | 471 | 0.47 | Why? |
| Stomach Neoplasms | 1 | 2016 | 477 | 0.44 | Why? |
| Iran | 14 | 2021 | 5467 | 0.43 | Why? |
| Biomarkers, Tumor | 1 | 2019 | 1314 | 0.40 | Why? |
| Wheat Hypersensitivity | 2 | 2019 | 13 | 0.39 | Why? |
| Interferon beta-1a | 3 | 2021 | 316 | 0.38 | Why? |
| Metabolic Syndrome | 1 | 2016 | 810 | 0.37 | Why? |
| Thioredoxins | 1 | 2018 | 25 | 0.19 | Why? |
| Glutens | 1 | 2019 | 55 | 0.19 | Why? |
| Toll-Like Receptor 9 | 1 | 2018 | 72 | 0.18 | Why? |
| Androgens | 1 | 2021 | 267 | 0.17 | Why? |
| Interferon beta-1b | 1 | 2020 | 274 | 0.17 | Why? |
| Toll-Like Receptor 2 | 1 | 2018 | 198 | 0.17 | Why? |
| Toll-Like Receptor 4 | 1 | 2018 | 390 | 0.14 | Why? |
| Toll-Like Receptor 7 | 1 | 2018 | 402 | 0.14 | Why? |
| Blood Proteins | 1 | 2018 | 551 | 0.14 | Why? |
| Helicobacter Infections | 1 | 2017 | 216 | 0.13 | Why? |
| Helicobacter pylori | 1 | 2017 | 262 | 0.13 | Why? |
| Interleukin-17 | 1 | 2018 | 602 | 0.13 | Why? |
| Indoles | 1 | 2021 | 1243 | 0.12 | Why? |
| Interleukins | 1 | 2018 | 762 | 0.12 | Why? |
| Intestinal Mucosa | 1 | 2018 | 1046 | 0.10 | Why? |
| Neoplasms | 1 | 2019 | 17251 | 0.10 | Why? |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2021 | 1510 | 0.09 | Why? |
| Patient Discharge | 2 | 2021 | 5696 | 0.09 | Why? |
| Bacterial Proteins | 1 | 2017 | 1318 | 0.09 | Why? |
| Tomography, X-Ray Computed | 4 | 2021 | 25144 | 0.08 | Why? |
| Stress, Psychological | 5 | 2021 | 10231 | 0.08 | Why? |
| Inflammation Mediators | 1 | 2018 | 2654 | 0.08 | Why? |
| Adult | 14 | 2021 | 244371 | 0.07 | Why? |
| Anxiety | 5 | 2021 | 17311 | 0.07 | Why? |
| Colorectal Neoplasms | 1 | 2018 | 1884 | 0.07 | Why? |
| Depression | 4 | 2021 | 14116 | 0.07 | Why? |
| Antiviral Agents | 3 | 2021 | 41703 | 0.06 | Why? |
| Survival Analysis | 1 | 2016 | 7592 | 0.06 | Why? |
| Humans | 24 | 2021 | 930598 | 0.06 | Why? |
| Surveys and Questionnaires | 5 | 2021 | 43792 | 0.06 | Why? |
| Cross-Sectional Studies | 5 | 2021 | 53120 | 0.06 | Why? |
| Middle Aged | 11 | 2021 | 270681 | 0.06 | Why? |
| Male | 14 | 2021 | 367725 | 0.06 | Why? |
| Risk Factors | 6 | 2021 | 71621 | 0.06 | Why? |
| Follow-Up Studies | 1 | 2021 | 17020 | 0.06 | Why? |
| Female | 14 | 2021 | 380317 | 0.06 | Why? |
| Lopinavir | 3 | 2021 | 4308 | 0.06 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.06 | Why? |
| Ritonavir | 3 | 2021 | 4212 | 0.06 | Why? |
| Students, Medical | 1 | 2021 | 4032 | 0.05 | Why? |
| Models, Statistical | 1 | 2018 | 5312 | 0.05 | Why? |
| Pneumonia | 1 | 2021 | 5652 | 0.05 | Why? |
| Drug Combinations | 2 | 2020 | 3852 | 0.05 | Why? |
| Epidemics | 1 | 2021 | 6407 | 0.05 | Why? |
| Renin | 1 | 2021 | 167 | 0.05 | Why? |
| Aldosterone | 1 | 2021 | 155 | 0.05 | Why? |
| Angiotensins | 1 | 2021 | 259 | 0.05 | Why? |
| Hypertension | 1 | 2021 | 8895 | 0.05 | Why? |
| Comorbidity | 2 | 2021 | 34796 | 0.05 | Why? |
| Biopsy | 2 | 2018 | 2811 | 0.05 | Why? |
| Lung | 3 | 2021 | 31049 | 0.04 | Why? |
| Adhesins, Bacterial | 1 | 2017 | 39 | 0.04 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.04 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.04 | Why? |
| Bacterial Outer Membrane Proteins | 1 | 2017 | 60 | 0.04 | Why? |
| Drug Therapy, Combination | 2 | 2021 | 7268 | 0.04 | Why? |
| Aged | 7 | 2021 | 215776 | 0.04 | Why? |
| Cytokines | 1 | 2018 | 15010 | 0.04 | Why? |
| Intestine, Small | 1 | 2018 | 336 | 0.04 | Why? |
| Life Expectancy | 1 | 2020 | 474 | 0.04 | Why? |
| Prognosis | 1 | 2019 | 32490 | 0.04 | Why? |
| Emigration and Immigration | 1 | 2020 | 501 | 0.04 | Why? |
| Virulence Factors | 1 | 2017 | 338 | 0.03 | Why? |
| Antigens, Bacterial | 1 | 2017 | 330 | 0.03 | Why? |
| Th17 Cells | 1 | 2018 | 657 | 0.03 | Why? |
| DNA, Bacterial | 1 | 2017 | 835 | 0.03 | Why? |
| Aspirin | 1 | 2021 | 1043 | 0.03 | Why? |
| Retrospective Studies | 5 | 2021 | 105322 | 0.03 | Why? |
| Cluster Analysis | 1 | 2020 | 3001 | 0.03 | Why? |
| New Zealand | 1 | 2019 | 2073 | 0.03 | Why? |
| Asia | 1 | 2019 | 2399 | 0.03 | Why? |
| Coronavirus | 1 | 2021 | 18339 | 0.03 | Why? |
| Dose-Response Relationship, Drug | 1 | 2020 | 3776 | 0.03 | Why? |
| Case-Control Studies | 2 | 2020 | 17671 | 0.03 | Why? |
| Virulence | 1 | 2017 | 2172 | 0.02 | Why? |
| Age Distribution | 1 | 2019 | 3567 | 0.02 | Why? |
| Hydroxychloroquine | 2 | 2021 | 12447 | 0.02 | Why? |
| Time Factors | 2 | 2020 | 31397 | 0.02 | Why? |
| Logistic Models | 1 | 2021 | 9089 | 0.02 | Why? |
| Prevalence | 2 | 2019 | 25773 | 0.02 | Why? |
| Australia | 1 | 2019 | 6306 | 0.02 | Why? |
| Gene Expression Regulation | 1 | 2018 | 4020 | 0.02 | Why? |
| Transcriptome | 1 | 2018 | 3466 | 0.02 | Why? |
| Genotype | 1 | 2017 | 4697 | 0.02 | Why? |
| Aged, 80 and over | 3 | 2021 | 88759 | 0.02 | Why? |
| Angiotensin Receptor Antagonists | 1 | 2021 | 3892 | 0.02 | Why? |
| Radiography, Thoracic | 1 | 2021 | 5486 | 0.02 | Why? |
| Survival Rate | 1 | 2018 | 9206 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2018 | 7220 | 0.02 | Why? |
| Europe | 1 | 2020 | 12702 | 0.02 | Why? |
| Mortality | 1 | 2020 | 7132 | 0.02 | Why? |
| Sex Factors | 1 | 2021 | 11014 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2018 | 9537 | 0.02 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 7868 | 0.02 | Why? |
| Young Adult | 3 | 2019 | 93724 | 0.02 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 5277 | 0.02 | Why? |
| Severity of Illness Index | 2 | 2021 | 48226 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2020 | 10649 | 0.01 | Why? |
| Hospitals | 1 | 2021 | 11793 | 0.01 | Why? |
| Pandemics | 4 | 2021 | 389249 | 0.01 | Why? |
| Immunity, Innate | 1 | 2018 | 6570 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2020 | 11041 | 0.01 | Why? |
| Adolescent | 2 | 2019 | 86841 | 0.01 | Why? |
| Incidence | 1 | 2019 | 25622 | 0.01 | Why? |
| Infant | 1 | 2019 | 30274 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2020 | 22116 | 0.01 | Why? |
| Biomarkers | 1 | 2018 | 23361 | 0.01 | Why? |
| Child, Preschool | 1 | 2019 | 36283 | 0.01 | Why? |
| Intensive Care Units | 1 | 2021 | 29594 | 0.01 | Why? |
| Treatment Outcome | 1 | 2020 | 51732 | 0.01 | Why? |
| Communicable Disease Control | 1 | 2021 | 29620 | 0.01 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.01 | Why? |
| Hospitalization | 1 | 2021 | 54280 | 0.01 | Why? |
| Child | 1 | 2019 | 70012 | 0.01 | Why? |
Pourhoseingholi's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(122)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(79)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_